Prognostic Potential of Heart Rate and Hypertension in Multiple Myeloma Patients
Background: The prognosis of patients with multiple myeloma (MM) is variable and partly depends on their cardiovascular status. The presence of arrhythmias can lead to worse outcomes. Therefore, this study aimed to evaluate the potential of heart rate (HR) and hypertension in predicating the outcome...
Main Authors: | Jie Wang, Manyun Tang, Yunxiang Long, Jingzhuo Song, Limei Chen, Mengchang Wang, Yongxin Li, Chaofeng Sun, Yang Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.681484/full |
Similar Items
-
Prevalence of Cardiovascular Events and Their Risk Factors in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Overlap Syndrome
by: Manyun Tang, et al.
Published: (2021-07-01) -
Testing Mayo Clinic’s New 20/20/20 Risk Model in Another Cohort of Smoldering Myeloma Patients: A Retrospective Study
by: Camille Tessier, et al.
Published: (2021-05-01) -
Echocardiography‐defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients
by: Yuan Jian, et al.
Published: (2022-11-01) -
Risk Stratification and Treatment in Smoldering Multiple Myeloma
by: Tyler Lussier, et al.
Published: (2021-12-01) -
Reversible Pulmonary Hypertension Related to Thalidomide Treatment for Multiple Myeloma
by: Antonio Villa, et al.
Published: (2011-09-01)